img

Global Monkeypox Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Monkeypox Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
Monkeypox Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monkeypox Vaccine market is projected to reach US$ 10 million in 2029, increasing from US$ 5 million in 2022, with the CAGR of 5.6% during the period of 2024 to 2029. Demand from Aldult and Child are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Monkeypox Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bavarian Nordic inks
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others

Segment by Application


Aldult
Child

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monkeypox Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Monkeypox Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Monkeypox Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Monkeypox Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Monkeypox Vaccine introduction, etc. Monkeypox Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Monkeypox Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Monkeypox Vaccine Market Overview
1.1 Monkeypox Vaccine Product Overview
1.2 Monkeypox Vaccine Market Segment by Type
1.2.1 DNA
1.2.2 Non-replicating Viral Vector
1.2.3 Protein Subunit
1.2.4 RNA
1.2.5 Others
1.3 Global Monkeypox Vaccine Market Size by Type
1.3.1 Global Monkeypox Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Monkeypox Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Monkeypox Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Monkeypox Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Monkeypox Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Monkeypox Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Monkeypox Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Monkeypox Vaccine Sales Breakdown by Type (2018-2024)
2 Global Monkeypox Vaccine Market Competition by Company
2.1 Global Top Players by Monkeypox Vaccine Sales (2018-2024)
2.2 Global Top Players by Monkeypox Vaccine Revenue (2018-2024)
2.3 Global Top Players by Monkeypox Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Monkeypox Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Monkeypox Vaccine Market Competitive Situation and Trends
2.5.1 Monkeypox Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Monkeypox Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monkeypox Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Monkeypox Vaccine Market
2.8 Key Manufacturers Monkeypox Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Monkeypox Vaccine Status and Outlook by Region
3.1 Global Monkeypox Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Monkeypox Vaccine Historic Market Size by Region
3.2.1 Global Monkeypox Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Monkeypox Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Monkeypox Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Monkeypox Vaccine Forecasted Market Size by Region
3.3.1 Global Monkeypox Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Monkeypox Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Monkeypox Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Monkeypox Vaccine by Application
4.1 Monkeypox Vaccine Market Segment by Application
4.1.1 Aldult
4.1.2 Child
4.2 Global Monkeypox Vaccine Market Size by Application
4.2.1 Global Monkeypox Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Monkeypox Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Monkeypox Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Monkeypox Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Monkeypox Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Monkeypox Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Monkeypox Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Monkeypox Vaccine Sales Breakdown by Application (2018-2024)
5 North America Monkeypox Vaccine by Country
5.1 North America Monkeypox Vaccine Historic Market Size by Country
5.1.1 North America Monkeypox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Monkeypox Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Monkeypox Vaccine Sales in Value by Country (2018-2024)
5.2 North America Monkeypox Vaccine Forecasted Market Size by Country
5.2.1 North America Monkeypox Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Monkeypox Vaccine Sales in Value by Country (2024-2029)
6 Europe Monkeypox Vaccine by Country
6.1 Europe Monkeypox Vaccine Historic Market Size by Country
6.1.1 Europe Monkeypox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Monkeypox Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Monkeypox Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Monkeypox Vaccine Forecasted Market Size by Country
6.2.1 Europe Monkeypox Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Monkeypox Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Monkeypox Vaccine by Region
7.1 Asia-Pacific Monkeypox Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Monkeypox Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Monkeypox Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Monkeypox Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Monkeypox Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Monkeypox Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Monkeypox Vaccine Sales in Value by Region (2024-2029)
8 Latin America Monkeypox Vaccine by Country
8.1 Latin America Monkeypox Vaccine Historic Market Size by Country
8.1.1 Latin America Monkeypox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Monkeypox Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Monkeypox Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Monkeypox Vaccine Forecasted Market Size by Country
8.2.1 Latin America Monkeypox Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Monkeypox Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Monkeypox Vaccine by Country
9.1 Middle East and Africa Monkeypox Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Monkeypox Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Monkeypox Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Monkeypox Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Monkeypox Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Monkeypox Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Monkeypox Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bavarian Nordic inks
10.1.1 Bavarian Nordic inks Company Information
10.1.2 Bavarian Nordic inks Introduction and Business Overview
10.1.3 Bavarian Nordic inks Monkeypox Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bavarian Nordic inks Monkeypox Vaccine Products Offered
10.1.5 Bavarian Nordic inks Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Monkeypox Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Monkeypox Vaccine Industrial Chain Analysis
11.4 Monkeypox Vaccine Market Dynamics
11.4.1 Monkeypox Vaccine Industry Trends
11.4.2 Monkeypox Vaccine Market Drivers
11.4.3 Monkeypox Vaccine Market Challenges
11.4.4 Monkeypox Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Monkeypox Vaccine Distributors
12.3 Monkeypox Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of DNA
Table 2. Major Company of Non-replicating Viral Vector
Table 3. Major Company of Protein Subunit
Table 4. Major Company of RNA
Table 5. Major Company of Others
Table 6. Global Monkeypox Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Monkeypox Vaccine Sales by Type (2018-2024) & (K Units)
Table 8. Global Monkeypox Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Monkeypox Vaccine Sales by Type (2018-2024) & (US& Million)
Table 10. Global Monkeypox Vaccine Market Share in Value by Type (2018-2024)
Table 11. Global Monkeypox Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 12. Global Monkeypox Vaccine Sales by Type (2024-2029) & (K Units)
Table 13. Global Monkeypox Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Monkeypox Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Monkeypox Vaccine Sales Market Share in Value by Type (2024-2029)
Table 16. Global Monkeypox Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 17. North America Monkeypox Vaccine Sales by Type (2018-2024) & (K Units)
Table 18. North America Monkeypox Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Monkeypox Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Europe Monkeypox Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Monkeypox Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Monkeypox Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Monkeypox Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Latin America Monkeypox Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Monkeypox Vaccine Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Monkeypox Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Monkeypox Vaccine Sales by Company (2018-2024) & (K Units)
Table 28. Global Monkeypox Vaccine Sales Share by Company (2018-2024)
Table 29. Global Monkeypox Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Monkeypox Vaccine Revenue Share by Company (2018-2024)
Table 31. Global Market Monkeypox Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 32. Global Monkeypox Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Monkeypox Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monkeypox Vaccine as of 2022)
Table 35. Date of Key Manufacturers Enter into Monkeypox Vaccine Market
Table 36. Key Manufacturers Monkeypox Vaccine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Monkeypox Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Monkeypox Vaccine Sales by Region (2018-2024) & (K Units)
Table 40. Global Monkeypox Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Monkeypox Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Monkeypox Vaccine Sales Market Share in Value by Region (2018-2024)
Table 43. Global Monkeypox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 44. Global Monkeypox Vaccine Sales by Region (2024-2029) & (K Units)
Table 45. Global Monkeypox Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Monkeypox Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Monkeypox Vaccine Sales Market Share in Value by Region (2024-2029)
Table 48. Global Monkeypox Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 49. Global Monkeypox Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Monkeypox Vaccine Sales by Application (2018-2024) & (K Units)
Table 51. Global Monkeypox Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Monkeypox Vaccine Sales Market Share in Value by Application (2018-2024)
Table 54. Global Monkeypox Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 55. Global Monkeypox Vaccine Sales by Application (2024-2029) & (K Units)
Table 56. Global Monkeypox Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Monkeypox Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Monkeypox Vaccine Sales Market Share in Value by Application (2024-2029)
Table 59. Global Monkeypox Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Monkeypox Vaccine Sales by Application (2018-2024) (K Units)
Table 61. North America Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Monkeypox Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Europe Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Monkeypox Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Monkeypox Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Latin America Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Monkeypox Vaccine Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Monkeypox Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Monkeypox Vaccine Sales by Country (2018-2024) & (K Units)
Table 71. North America Monkeypox Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Monkeypox Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Monkeypox Vaccine Sales Market Share in Value by Country (2018-2024)
Table 74. North America Monkeypox Vaccine Sales by Country (2024-2029) & (K Units)
Table 75. North America Monkeypox Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Monkeypox Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Monkeypox Vaccine Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Monkeypox Vaccine Sales by Country (2018-2024) & (K Units)
Table 79. Europe Monkeypox Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Monkeypox Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Monkeypox Vaccine Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Monkeypox Vaccine Sales by Country (2024-2029) & (K Units)
Table 83. Europe Monkeypox Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Monkeypox Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Monkeypox Vaccine Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Monkeypox Vaccine Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Monkeypox Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Monkeypox Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Monkeypox Vaccine Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Monkeypox Vaccine Sales by Region (2024-2029) & (K Units)
Table 91. Asia-Pacific Monkeypox Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Monkeypox Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Monkeypox Vaccine Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Monkeypox Vaccine Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Monkeypox Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Monkeypox Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Monkeypox Vaccine Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Monkeypox Vaccine Sales by Country (2024-2029) & (K Units)
Table 99. Latin America Monkeypox Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Monkeypox Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Monkeypox Vaccine Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Monkeypox Vaccine Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Monkeypox Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Monkeypox Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Monkeypox Vaccine Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Monkeypox Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Middle East and Africa Monkeypox Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Monkeypox Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Monkeypox Vaccine Sales Market Share in Value by Country (2024-2029)
Table 110. Bavarian Nordic inks Company Information
Table 111. Bavarian Nordic inks Introduction and Business Overview
Table 112. Bavarian Nordic inks Monkeypox Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Bavarian Nordic inks Monkeypox Vaccine Product
Table 114. Bavarian Nordic inks Recent Development
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Monkeypox Vaccine Market Trends
Table 118. Monkeypox Vaccine Market Drivers
Table 119. Monkeypox Vaccine Market Challenges
Table 120. Monkeypox Vaccine Market Restraints
Table 121. Monkeypox Vaccine Distributors List
Table 122. Monkeypox Vaccine Downstream Customers
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Monkeypox Vaccine Product Picture
Figure 2. Global Monkeypox Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Monkeypox Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Monkeypox Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of DNA
Figure 6. Global DNA Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Non-replicating Viral Vector
Figure 8. Global Non-replicating Viral Vector Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Protein Subunit
Figure 10. Global Protein Subunit Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of RNA
Figure 12. Global RNA Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Global Monkeypox Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Monkeypox Vaccine Sales Market Share by Type in 2022 & 2029
Figure 17. North America Monkeypox Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. North America Monkeypox Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Europe Monkeypox Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Monkeypox Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Monkeypox Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Monkeypox Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Monkeypox Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Monkeypox Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Monkeypox Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Monkeypox Vaccine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Monkeypox Vaccine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Monkeypox Vaccine Revenue in 2022
Figure 29. Monkeypox Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Aldult
Figure 31. Global Aldult Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Child
Figure 33. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Monkeypox Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Monkeypox Vaccine Sales Market Share by Application in 2022 & 2029
Figure 36. North America Monkeypox Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. North America Monkeypox Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Europe Monkeypox Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Europe Monkeypox Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Monkeypox Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Monkeypox Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Latin America Monkeypox Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Monkeypox Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Monkeypox Vaccine Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Monkeypox Vaccine Manufacturing Cost Structure
Figure 47. Monkeypox Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed